Serum relaxin-3 and galanin levels in individuals with erectile dysfunction with and without type 2 diabetes mellitus
dc.contributor.author | Yılmaz, Ümit | |
dc.contributor.author | Burlukkara, Salih | |
dc.contributor.author | Demir, Demirhan Orsan | |
dc.date.accessioned | 2024-12-26T12:17:46Z | |
dc.date.available | 2024-12-26T12:17:46Z | |
dc.date.issued | 2024 | |
dc.department | Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | |
dc.description.abstract | This study was designed to determine the serum relaxin-3 and galanin levels in individuals with erectile dysfunction with and without type 2 diabetes mellitus (T2DM). A total of 154 individuals aged 30-60 were included in the study and the participants were divided into three groups: D-ED group (individuals with T2DM and ED) (n=49), ND-ED group (individuals with ED without T2DM) (n=55), and control group (individuals without T2DM and ED) (n=50). The age, BMI, and IIEF-5 score were recorded for all participants. The HDL, LDL, triglycerides, cholesterol, HbA1c and testosterone were determined from the blood taken from the participants, and galanin and relaxin-3 levels were measured in serum samples by ELISA method. The IIEF-5 score of the D-ED group was statistically lower than that of the ND-ED and control groups, and the IIEF-5 score of the ND-ED group was also lower than that of the control group. Serum testosterone levels in the control group were statistically higher than in the D-ED and ND-ED groups. The galanin level of the D-ED group was elevated than the control and ND-ED groups, but the galanin level of the ND-ED group was lower than the control group. The relaxin-3 levels were decreased in the D-ED and ND-ED groups compared to the control group. Galanin levels increased in individuals with T2DM and ED, however decreased in individuals with ED without T2DM. In addition, reduced relaxin-3 level may play a role in the development of ED. | |
dc.identifier.doi | 10.5455/medscience.2024.07.077 | |
dc.identifier.endpage | 666 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 661 | |
dc.identifier.trdizinid | 1282496 | |
dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/1282496 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14619/14893 | |
dc.identifier.volume | 13 | |
dc.indekslendigikaynak | TR-Dizin | |
dc.relation.ispartof | Medicine Science | |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Erectile dysfunction | |
dc.subject | Type 2 diabetes mellitus | |
dc.subject | Testosterone | |
dc.subject | IIEF-5 | |
dc.subject | galanin | |
dc.subject | Relaxin-3 | |
dc.title | Serum relaxin-3 and galanin levels in individuals with erectile dysfunction with and without type 2 diabetes mellitus | |
dc.type | Article |